Clinical studies recruiting near Walnut Creek

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Kaiser Permanente - Walnut Creek ( Site 0078) · Merck Sharp & Dohme LLC · NCT06393374 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Kaiser Permanente-Walnut Creek · National Cancer Institute (NCI) · NCT05564390 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · Kaiser Permanente-Walnut Creek · NRG Oncology · NCT05946213 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Kaiser Permanente-Walnut Creek · NRG Oncology · NCT05174169 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Kaiser Permanente-Walnut Creek · Alliance for Clinical Trials in Oncology · NCT06632327 Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastati
Phase 3 · Kaiser Permanente-Walnut Creek · Alliance for Clinical Trials in Oncology · NCT06931340 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Kaiser Permanente-Walnut Creek · Alliance for Clinical Trials in Oncology · NCT06876714 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · Kaiser Permanente-Walnut Creek · NRG Oncology · NCT06748222 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · John Muir Medical Center-Walnut Creek · National Cancer Institute (NCI) · NCT05256225 Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associate
Phase 3 · Sunwise Clinical Research, LLC - Walnut Creek - IVY - PPDS · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05980949 Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-S
Phase 3 · Kaiser Permanente-Walnut Creek · National Cancer Institute (NCI) · NCT06498635 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Kaiser Permanente-Walnut Creek · NRG Oncology · NCT04852887 Vancomycin Reduction Practices (VRP) in the NICU
NA · Kaiser Permanente Walnut Creek Medical Center · Children's Hospital of Philadelphia · NCT06772675 mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Neg
Phase 3 · Kaiser Permanente-Walnut Creek · Alliance for Clinical Trials in Oncology · NCT05677490 A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
Phase N/A · Kaiser Permanente Walnut Creek Medical Center · Pfizer · NCT05452941 Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Kaiser Permanente-Walnut Creek · National Cancer Institute (NCI) · NCT05987241 A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT
Phase 3 · Sunwise Clinical Research, LLC - Walnut Creek - IVY - PPDS · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05511363 Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Trea
Phase 2 · Kaiser Permanente-Walnut Creek · National Cancer Institute (NCI) · NCT06317649 A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Phase 3 · Kaiser Permanente-Walnut Creek · National Cancer Institute (NCI) · NCT05675410 Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had
Phase 2/Phase 3 · Kaiser Permanente-Walnut Creek · SWOG Cancer Research Network · NCT06616584 S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · Kaiser Permanente-Walnut Creek · SWOG Cancer Research Network · NCT03418961 A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Phase 3 · Kaiser Permanente Walnut Creek · Pfizer · NCT07282665 Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Meta
Phase 2 · Kaiser Permanente-Walnut Creek · National Cancer Institute (NCI) · NCT06029270 Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Diffe
Phase 3 · Kaiser Permanente-Walnut Creek · National Cancer Institute (NCI) · NCT06422806 A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants Wit
Phase 3 · Golden State Dermatology - Walnut Creek - Ygnacio Valley Roa · Bristol-Myers Squibb · NCT06979453 Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · Kaiser Permanente-Walnut Creek · National Cancer Institute (NCI) · NCT04267848 Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Phase 2/Phase 3 · Kaiser Permanente-Walnut Creek · SWOG Cancer Research Network · NCT03851445 High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Che
Phase 3 · Kaiser Permanente-Walnut Creek · Alliance for Clinical Trials in Oncology · NCT06992427 A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NA · Kaiser Permanente-Walnut Creek · NRG Oncology · NCT04251052 Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Phase 3 · Kaiser Permanente-Walnut Creek · NRG Oncology · NCT06580314

Look up another city

Look up another condition